The pharmaceutical industry operates under strict regulations. Real-time visibility ensures order accuracy, effective inventory management and compliance. The intricate global sourcing, outsourcing and new modalities make it challenging to maintain resilience and efficiency in the face of disruptions. Moreover, counterfeit drugs pose a significant risk to patient safety and industry credibility.
In this webinar, IDC analysts Simon Ellis and Michael Townsend will share findings from their latest primary research focusing on hot industry trends, market needs and innovative technologies to address critical supply chain challenges
Tune in for...
Simon’s expertise lies in advising clients on manufacturing strategies and supply chain digital transformation. With over 35 years of experience in the manufacturing industry, he has worked across all major areas of the supply chain including roles as a manufacturing technologist and business leader in both operational and strategic supply chain functions. His insights drive industry advancements and guide organizations toward resilient and efficient supply chains.
Michael Townsend
Research Director, Life Sciences Commercialization Strategies | IDC
With over 20 years of engineering and operations management experience with manufacturers serving the life sciences industry, Michael provides research-based advisory and consulting services. His expertise spans sales and marketing, supply chain, manufacturing systems, and emerging technologies and marketing trends.